Osaka Metropolitan University and Cosomil have announced a collaborative research partnership to advance the detection of hepatocellular carcinoma (HCC), biliary tract cancer, and pancreatic cancer. This research aims to conduct initial studies for the development of a recurrence risk test for pancreatic cancer and a diagnostic test for hepatobiliary cancer.